The store will not work correctly when cookies are disabled.
(4-(2,4-difluorophenethyl)piperazin-1-yl)(pyrazolo[1,5-a]pyridin-7-yl)methanone
ID: ALA1957805
PubChem CID: 57400053
Max Phase: Preclinical
Molecular Formula: C20H20F2N4O
Molecular Weight: 370.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(c1cccc2ccnn12)N1CCN(CCc2ccc(F)cc2F)CC1
Standard InChI: InChI=1S/C20H20F2N4O/c21-16-5-4-15(18(22)14-16)7-9-24-10-12-25(13-11-24)20(27)19-3-1-2-17-6-8-23-26(17)19/h1-6,8,14H,7,9-13H2
Standard InChI Key: HGKUJSGVRNNXTO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-3.3601 -9.0813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0344 -8.3185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.1802 -9.0037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3643 -8.1993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6568 -7.7789 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6682 -6.9580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3862 -6.5565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0943 -6.9819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0794 -7.8014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2380 -6.9558 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2380 -7.7809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5258 -8.1893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8137 -7.7809 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8137 -6.9558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5258 -6.5390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9539 -6.5453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9563 -5.7201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0996 -8.1945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6156 -7.7829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3296 -8.1966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3255 -9.0197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0387 -9.4333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7549 -9.0217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7534 -8.1922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0397 -7.7824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0369 -6.9573 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.4695 -9.4344 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
3 1 1 0
10 16 1 0
7 8 1 0
16 17 2 0
13 18 1 0
8 9 2 0
18 19 1 0
9 4 1 0
19 20 1 0
10 11 1 0
20 21 2 0
1 2 2 0
21 22 1 0
4 5 1 0
22 23 2 0
2 5 1 0
23 24 1 0
5 6 1 0
24 25 2 0
25 20 1 0
4 3 2 0
25 26 1 0
6 7 2 0
23 27 1 0
16 6 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 370.40 | Molecular Weight (Monoisotopic): 370.1605 | AlogP: 2.61 | #Rotatable Bonds: 4 |
Polar Surface Area: 40.85 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.24 | CX LogP: 2.87 | CX LogD: 2.84 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.71 | Np Likeness Score: -2.03 |
References
1. Xiong Y, Ullman B, Choi JS, Cherrier M, Strah-Pleynet S, Decaire M, Feichtinger K, Frazer JM, Yoon WH, Whelan K, Sanabria EK, Grottick AJ, Al-Shamma H, Semple G.. (2012) Identification of fused bicyclic heterocycles as potent and selective 5-HT(2A) receptor antagonists for the treatment of insomnia., 22 (5): [PMID:22325948] [10.1016/j.bmcl.2012.01.080] |